[1] |
中华医学会妇产科学分会内分泌学组. 女性高催乳素血症诊治共识[J]. 中华妇产科杂志,2016, 51(3): 161-168.
|
[2] |
Ajmal A,Joffe H, Nachtigall LB. Psychotropic-induced hyperprolactinemia: a clinical review[J]. Psychosomatics, 2014, 55(1): 29-36.
|
[3] |
Stroup TS, Gray N. Management of common adverse effects of antipsychotic medications[J]. World Psychiatry, 2018, 17(3): 341-356.
|
[4] |
González-Blanco L, Greenhalgh AMD, Garcia-Rizo C, et al. Prolactin concentrations in antipsychotic-naïve patients with schizophrenia and related disorders: a Meta-analysis[J]. Schizophr Res, 2016, 174(1-3): 156-160.
|
[5] |
Stubbs B, De Hert M, Sepehry AA, et al. A Meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia[J]. Acta Psychiatr Scand, 2014, 130(6): 470-486.
|
[6] |
Catalá-López F, Suárez-Pinilla M, Suárez-Pinilla P, et al. Inverse and direct cancer comorbidity in people with central nervous system disorders: a Meta-analysis of cancer incidence in 577 013 participants of 50 observational studies[J]. Psychother Psychosom, 2014, 83(2): 89-105.
|
[7] |
周平,刘联琦,郝军锋,等. 阿立哌唑预防女性分裂症患者抗精神病药所致高泌乳素血症的研究[J]. 国际精神病学杂志,2014, 41(2): 68-72.
|
[8] |
邓良华,刘青梅,郑庆梅. 非典型抗精神病药引起女性闭经的调查[J]. 吉林医学,2008, 29(15): 1254-1255.
|
[9] |
Melkersson K. Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients[J]. J Clin Psychiatry, 2005, 66(6): 761-767.
|
[10] |
Bargiota SI, Bonotis KS, Messinis IE, et al. The effects of antipsychotics on prolactin levels and women′s menstruation[J]. Schizophr Res Treatment, 2013, 2013: 502697.
|
[11] |
赵中健,孔德荣,李猛,等. 阿立哌唑、齐拉西酮与利培酮对女性精神分裂症患者雌二醇水平的影响[J]. 精神医学杂志,2015, 28(1): 13-15.
|
[12] |
Chen JX, Su YN, Bian QT, et al. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: a randomized, double-blind, placebo-controlled, dose-response study[J]. Psychoneuroendocrinology, 2015, 58: 130-140.
|
[13] |
Yoon HW, Lee JS, Park SJ, et al. Comparing the effectiveness and safety of the addition of and switching toaripiprazole for resolving antipsychotic-induced hyperprolactinemia: a multicenter, open-label, prospective study[J]. Clin Neuropharmacol, 2016, 39(6): 288-294.
|
[14] |
Bargiota SI, Bonotis K, Messinis IE, et al. Hyperprolactinaemia: psychological aspects and menstrual attitudes of women with schizophrenia[J]. Psychiatry Res, 2015, 226(2-3): 525.
|
[15] |
喻东山,高振忠. 精神科合理用药手册[M]. 南京:江苏科学技术出版社,2005: 65-170.
|
[16] |
Marken PA,Haykal RF, Fisher JN. Management of psychotropic-induced hyperprolactinemia[J]. Clin Pharm, 1992, 11(10): 851-856.
|
[17] |
余云香,吕那,李宇晨,等. 抗精神病药物致高泌乳素血症对女性精神病患者卵巢功能的影响[J]. 中国医药指南,2016, 14(26): 7-8.
|
[18] |
Canuso CM, Goldstein JM,Wojcik J, et al. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder[J]. Psychiatry Res, 2002, 111(1): 11-20.
|
[19] |
Chen HZ,Qian MC, Shen XH, et al. Risk factors for medication-induced amenorrhea in first-episode female Chinese patients with schizophrenia treated with risperidone[J]. Shanghai Arch Psychiatry, 2013, 25(1): 40-47.
|
[20] |
Reynolds-May MF,Kenna HA, Marsh W, et al. Evaluation of reproductive function in women treated for bipolar disorder compared to healthy controls[J]. Bipolar Disord, 2014, 16(1): 37-47.
|
[21] |
郑婵燕,周平,李祎鋆,等. 逍遥丸治疗女性精神分裂症患者抗精神病药致高泌乳素血症的对照研究[J]. 实用医学杂志,2015, 31(2): 309-311.
|
[22] |
苏珊娜,刘临兰,杨宇,等. 丹溪治湿痰方治疗抗精神病药物所致闭经临床观察[J]. 深圳中西医结合杂志,2016, 26(16): 48-49.
|